Conceptualising the neurobiology of fatigue

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 4, 2013, Pages 312-316

  Hegerl, Ulrich ^a   Lam, Raymond W ^b   Malhi, Gin S ^c,d   McIntyre, Roger S ^e   Demyttenaere, Koen ^f   Mergl, Roland ^a   Gorwood, Philip ^g  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PSYCHOSTIMULANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CHRONIC FATIGUE SYNDROME; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FIBROMYALGIA; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOPATHOLOGY; INFLAMMATION; MAJOR DEPRESSION; NEUROBIOLOGY; SLEEP; TREATMENT RESPONSE; VIRUS INFECTION; WAKEFULNESS;

AROUSAL; CHRONIC DISEASE; FATIGUE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION MEDIATORS; PITUITARY-ADRENAL SYSTEM;

EID: 84880522955     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413481505     Document Type: Article

References (30)

1. Arnett SV, Alleva LM, Korossy-Horwood R, et al. (2011) Chronic fatigue syndrome-A neuroimmunological model. Medical Hypotheses 77: 77-83.
2. Candy M, Jones L, Williams R, et al. (2008) Psychostimulants for depression. Cochrane Database Systematic Reviews (2): CD006722.
3. Capuron L, Ravaud A, Neveu PJ, et al. (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry 7: 468-473.
4. Cleare AJ (2004) The HPA axis and the genesis of chronic fatigue syndrome. Trends in Endocrinology and Metabolism 15: 55-59.
5. Cleare AJ, Heap E, Malhi GS, et al. (1999) Lowdose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial. The Lancet 353: 455-458.
6. Demyttenaere K, De Fruyt J and Stahl SM (2005) The many faces of fatigue in major depressive disorder. International Journal of Neuropsychopharmacology 8: 93-105.
7. Günther T, Schönknecht P, Becker G, et al. (2011) Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage 56: 93-101.
8. Hegerl U and Hensch T (2012) The vigilance regulation model of affective disorders and ADHD. Neuroscience and Biobehavioral Reviews. Epub ahead of print, 22 October 2012. doi: 10.1016/ j.neubiorev.2012.10.008.
9. Hegerl U, Wilk K, Olbrich S, et al. (2012) Hyperstable regulation of vigilance in patients with major depressive disorder. World Journal of Biological Psychiatry 13: 436-446.
10. Heim C, Nater UM, Maloney E, et al. (2009) Childhood trauma and risk for chronic fatigue syndrome: Association with neuroendocrine dysfunction. Archives of General Psychiatry 66: 72-80.
11. Himmerich H, Fulda S, Linseisen J, et al. (2008) Depression, comorbidities and the TNF-alpha system. European Psychiatry 23: 421-429.
12. Hohl-Radke F (2008) [On the psychopathology and neurobiology of the term 'Antrieb' (drive, impulse). ] Schweizer Archiv für Neurologie und Psychiatrie 159: 365-377.
13. Hubain P, Le Bon O, Vandenhende F, et al. (2006) Major depression in males: Effects of age, severity and adaptation on sleep variables. Psychiatry Research 145: 169-177.
14. Iaboni A, Ibanez D, Gladman DD, et al. (2006) Fatigue in systemic lupus erythematosus: Contributions of disordered sleep, sleepiness, and depression. Journal of Rheumatology 33: 2453-2457.
15. Jean-Pierre P, Morrow GR, Roscoe JA, et al. (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: A University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 116: 3513-3520.
16. McKenzie R, O'Fallon A, Dale J, et al. (1998) Lowdose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial. Journal of the American Medical Association 280: 1061-1066.
17. Minton O, Richardson A, Sharpe M, et al. (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Journal of the National Cancer Institute 100: 1155-1166.
18. Minton O, Richardson A, Sharpe M, et al. (2010) Drug therapy for the management of cancerrelated fatigue. Cochrane Database Systematic Reviews (7): CD006704.
19. Müller N and Schwarz MJ (2007) The immunemediated alteration of serotonin and glutamate: Towards an integrated view of depression. Molecular Psychiatry 12: 988-1000.
20. Neu D, Hoffmann G, Moutrier R, et al. (2008) Are patients with chronic fatigue syndrome just 'tired' or also 'sleepy'? Journal of Sleep Research 17: 427-431.
21. Neumeister A (2003) Tryptophan depletion, serotonin, and depression: Where do we stand? Psychopharmacological Bulletin 37: 99-115.
22. Nofzinger EA, Thase ME, Reynolds CF 3rd, et al. (1991) Hypersomnia in bipolar depression: A comparison with narcolepsy using the multiple sleep latency test. American Journal of Psychiatry 148: 1177-1181.
23. Olbrich S, Sander C, Jahn I, et al. (2012) Unstable EEG-vigilance in patients with cancer-related fatigue (CRF) in comparison to healthy controls. World Journal of Biological Psychiatry 13: 146-152.
24. Olbrich S, Sander C, Matschinger H, et al. (2011) Brain and body - Associations between EEGvigilance and the autonomous nervous system activity during rest. Journal of Psychophysiology 25: 190-200.
25. Pariante CM and Lightman SL (2008) The HPA axis in major depression: Classical theories and new developments. Trends in Neuroscience 31: 464-468.
26. Shen J, Hossain N, Streiner DL, et al. (2011) Excessive daytime sleepiness and fatigue in depressed patients and therapeutic response of a sedating antidepressant. Journal of Affective Disorders 134: 421-426.
27. Silverman MN, Heim CM, Nater UM, et al. (2010) Neuroendocrine and immune contributors to fatigue. PM & R: The Journal of Injury, Function, and Rehabilitation 2: 338-346.
28. Spitzer AR and Broadman M (2010) A retrospective review of the sleep characteristics in patients with chronic fatigue syndrome and fibromyalgia. Pain Practice 10: 294-300.
29. Stone EA, Lin Y, Sarfraz Y, et al. (2011) The role of the central noradrenergic system in behavioral inhibition. Brain Research Reviews 67: 193-208.
30. West CH, Ritchie JC, Boss-Williams KA, et al. (2009) Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. International Journal of Neuropsychopharmacology 12: 627-641.